AVITA Medical (RCEL) Interest Expenses (2018 - 2025)

AVITA Medical's Interest Expenses history runs 8 years deep, the most recent figure standing at $1.2 million for Q4 2025.

• Quarterly Interest Expenses fell 5.47% year-over-year to $1.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.0 million (down 7.09% YoY) and the FY2025 annual result came in at $73.3 million, up 21.36% from the prior year.
• Interest Expenses was $1.2 million for Q4 2025 at AVITA Medical, down from $1.3 million in the prior quarter.
• Across five years, Interest Expenses topped out at $51.3 million in Q4 2021 and bottomed at -$582000.0 in Q4 2022.
• A 5-year average of $3.6 million and a median of $1.2 million in 2025 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2021 — Interest Expenses soared 3720.0% — and 2022, when it tumbled 101.13%.
• AVITA Medical's Interest Expenses stood at $51.3 million in 2021, then tumbled by 101.13% to -$582000.0 in 2022, then jumped by 292.78% to $1.1 million in 2023, then grew by 15.6% to $1.3 million in 2024, then declined by 5.47% to $1.2 million in 2025.
• Business Quant data shows RCEL's Interest Expenses at $1.2 million in Q4 2025, $1.3 million in Q3 2025, and $1.3 million in Q2 2025.